|
1
|
Hayflick L and Moorhead PS: The serial
cultivation of human diploid cell strains. Exp Cell Res.
25:585–621. 1961. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ohtani N, Mann DJ and Hara E: Cellular
senescence: its role in tumor suppression and aging. Cancer Sci.
100:792–797. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Collado M, Gil J, Efeyan A, Guerra C,
Schuhmacher AJ, Barradas M, et al: Tumour biology: senescence in
premalignant tumours. Nature. 436:6422005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nickoloff BJ, Lingen MW, Chang BD, Shen M,
Swift M, Curry J, et al: Tumor suppressor maspin is up-regulated
during keratinocyte senescence, exerting a paracrine antiangiogenic
activity. Cancer Res. 64:2956–2961. 2004. View Article : Google Scholar
|
|
5
|
Parkin DM, Pisani P and Ferlay J: Global
cancer statistics. CA Cancer J Clin. 49:33–64. 1999. View Article : Google Scholar
|
|
6
|
Chen Z, Trotman LC, Shaffer D, Lin HK,
Dotan ZA, Niki M, et al: Crucial role of p53-dependent cellular
senescence in suppression of Pten-deficient tumorigenesis. Nature.
436:725–730. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Michaloglou C, Vredeveld LC, Soengas MS,
et al: BRAFE600-associated senescence-like cell cycle arrest of
human naevi. Nature. 436:720–724. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Braig M, Lee S, Loddenkemper C, Rudolph C,
Peters AH, Schlegelberger B, et al: Oncogene-induced senescence as
an initial barrier in lymphoma development. Nature. 436:660–665.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vered M, Allon I and Dayan D: Maspin, p53,
p63, and Ki-67 in epithelial lesions of the tongue: from
hyperplasia through dysplasia to carcinoma. J Oral Pathol Med.
38:314–320. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Soni S, Kaur J, Kumar A, Chakravarti N,
Mathur M, Bahadur S, et al: Alterations of Rb pathway components
are frequent events in patients with oral epithelial dysplasia and
predict clinical outcome in patients with squamous cell carcinoma.
Oncology. 68:314–325. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Itahana K, Dimri G and Campisi J:
Regulation of cellular senescence by p53. Eur J Biochem.
268:2784–2789. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shangary S, Qin D, McEachern D, Liu M,
Miller RS, Qiu S, et al: Temporal activation of p53 by a specific
MDM2 inhibitor is selectively toxic to tumors and leads to complete
tumor growth inhibition. Proc Natl Acad Sci USA. 105:3933–3938.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lavertu P, Adelstein DJ, Myles J and Secic
M: P53 and Ki-67 as outcome predictors for advanced squamous cell
cancers of the head and neck treated with chemoradiotherapy.
Laryngoscope. 111:1878–1892. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tu HF, Chen HW, Kao SY, Lin SC, Liu CJ and
Chang KW: MDM2 SNP 309 and p53 codon 72 polymorphisms are
associated with the outcome of oral carcinoma patients receiving
postoperative irradiation. Radiother Oncol. 87:243–252. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang SF, Chen IH, Liao CT, Wang HM, Liou
SH and Hsieh LL: Combined effects of MDM2 SNP 309 and p53 mutation
on oral squamous cell carcinomas associated with areca quid
chewing. Oral Oncol. 45:16–22. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Campo-Trapero J, Cano-Sánchez J,
Palacios-Sánchez B, Sánchez-Gutiérrez JJ, González-Moles MA and
Bascones-Martínez A: Update on molecular pathology in oral cancer
and precancer. Anticancer Res. 28:1197–1205. 2008.PubMed/NCBI
|
|
17
|
El-Naggar AK, Lai S, Clayman GL, Zhou JH,
Tucker SA, Myers J, et al: Expression of p16, Rb, and cyclin D1
gene products in oral and laryngeal squamous carcinoma: biological
and clinical implications. Hum Pathol. 30:1013–1018. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu HS, Lu HH, Lui MT, Yu EH, Shen W, Chen
YP, et al: Detection of copy number amplification of cyclin D1
(CCND1) and cortactin (CTTN) in oral carcinoma and oral brushed
samples from areca chewers. Oral Oncol. 45:1032–1036. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Myo K, Uzawa N, Miyamoto R, Sonoda I, Yuki
Y and Amagasa T: Cyclin D1 gene numerical aberration is a
predictive marker for occult cervical lymph node metastasis in TNM
stage I and II squamous cell carcinoma of the oral cavity. Cancer.
104:2709–2716. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
De Vicente JC, Herrero-Zapatero A, Fresno
MF and López-Arranz JS: Expression of cyclin D1 and Ki-67 in
squamous cell carcinoma of the oral cavity: clinicopathological and
prognostic significance. Oral Oncol. 38:301–308. 2002.PubMed/NCBI
|
|
21
|
Sathyan KM, Nalinakumari KR, Abraham T and
Kannan S: CCND1 polymorphisms (A870G and C1722G) modulate its
protein expression and survival in oral carcinoma. Oral Oncol.
44:689–697. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Marioni G, Gaio E, Giacomelli L, Bertolin
A, D’Alessandro E, Stramare R, et al: Maspin subcellular
localization and expression in oral cavity squamous cell carcinoma.
Eur Arch Otorhinolaryngol. 265:S97–104. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cho JH, Kim HS, Park CS, Kim JK, Jung KY,
Shin BK, et al: Maspin expression in early oral tongue cancer and
its relation to expression of mutant-type p53 and vascular
endothelial growth factor (VEGF). Oral Oncol. 43:272–277. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yasumatsu R, Nakashima T, Hirakawa N,
Kumamoto Y, Kuratomi Y, Tomita K, et al: Maspin expression in stage
I and II oral tongue squamous cell carcinoma. Head Neck.
23:962–966. 2001. View
Article : Google Scholar : PubMed/NCBI
|
